Stirlingshire Investments Fined ,000 for Failing to Supervise NT-ETF Sales

Stirlingshire Investments Fined $40,000 for Failing to Supervise NT-ETF Sales

Stirlingshire Investments, a well-established broker-dealer based in New York City, recently found itself at the center of a significant regulatory action involving supervisory failures and investor risk. As a retail investor, you depend on your financial advisor to recommend products that are in your best interest, assuming the firm itself enforces robust compliance and oversight. But what if those supervisory guardrails break down? The Stirlingshire Investments case provides important lessons for anyone entrusting their savings to financial professionals.

The Stirlingshire Case: A Breakdown in Oversight

In January 2026, the Financial Industry Regulatory Authority (FINRA) issued a Letter of Acceptance, Waiver, and Consent (AWC No. 2023077093401) against Stirlingshire Investments (CRD# 310576). The firm was censured and fined $40,000 after regulators determined it had failed to supervise the sale of complex, high-risk financial products known as non-traditional exchange-traded funds (NT-ETFs). These investments, which include leveraged and inverse ETFs, are designed to amplify daily gains—but they can also exponentially magnify losses, making them especially perilous for most investors.

Between November 2022 and April 2024, three representatives at Stirlingshire Investments recommended NT-ETFs to over 25 retail clients. Unlike traditional mutual funds, NT-ETFs are engineered to deliver multiples of a referenced index on a daily basis—sometimes two or three times the daily move, or even the inverse. Holding these funds for longer than a single trading session can trigger unexpected—and sometimes severe—losses due to the effects of daily compounding. Even experienced investors can be caught off guard by these products’ behavior.

What Went Wrong: Supervision and Systemic Gaps

The central issue? Although Stirlingshire Investments documented a policy that explicitly prohibited its representatives from purchasing NT-ETFs in customer accounts, the firm failed to enforce that rule. Supervisors were instructed to block these transactions, but in reality, no surveillance software, compliance alerts, or checks were set up. This allowed inappropriate recommendations to slip through, exposing clients to unnecessary risk.

To summarize:

  • No technological tools or surveillance systems detected the prohibited trades.
  • Supervisory staff were unaware of the breaches or failed to take action.
  • The written procedures remained only words on paper—not an actual shield for investors.

According to the FINRA letter, Stirlingshire Investments “failed to establish, maintain, and enforce a reasonable supervisory system, including written supervisory procedures,” specifically regarding the recommendation of NT-ETFs. The investigation further found violations of Regulation Best Interest (Reg BI), a federal rule mandating that brokers act in their clients’ best interest when making any securities recommendation.

Additional Issues: Private Placement Disclosure Failures

The regulatory action didn’t stop with ETFs. The AWC also revealed that Stirlingshire Investments facilitated two private placement offerings, selling unregistered securities issued by its own parent company to 21 investors. These investors did not receive the required private placement memorandums, nor did the firm file necessary documentation with FINRA. While private placements are exempt from SEC registration, they still require adequate disclosure and filings to protect investors.

These lapses suggest the firm was either overwhelmed, did not have sufficient compliance infrastructure, or failed to prioritize its regulatory duties. In some cases, such problems can persist at firms for years, resulting in repeated harms to unsuspecting investors. According to Investopedia, investment fraud complaints most commonly arise when firms neglect their supervisory responsibilities, allowing advisors to recommend unsuitable or outright fraudulent products.

Who Is Stirlingshire Investments?

Stirlingshire Investments is a registered broker-dealer located in New York City, listed under CRD# 310576 on FINRA BrokerCheck. The firm employs multiple registered representatives, three of whom were found to have recommended NT-ETFs against firm policy. While the AWC does not identify these advisors by name or individual CRD number, anyone can review firm or individual records by using FINRA’s free BrokerCheck tool. Researching a firm or advisor’s past complaints, regulatory actions, or disciplinary events is a vital step before investing.

Why does due diligence matter? Statistics from the SEC and investor advocacy groups show that roughly 7% of financial advisors have a disclosure event on record. Remarkably, this relatively small group is linked to a majority of customer complaints and investor losses. Problematic advisors often move between firms, making it essential for investors to check the history and reputation of both firms and individuals.

Key Facts: Stirlingshire Investments Case Details
Firm Name Stirlingshire Investments
CRD Number 310576
Location New York City, NY
FINRA AWC Number 2023077093401
Regulatory Action Date January 2026
Fine Amount $40,000
Period of Conduct NT-ETFs: Nov 2022 – Apr 2024
Products at Issue Non-traditional Exchange-Traded Funds, Private Placements
Number of Customers Affected 25+ (NT-ETFs); 21 (Private Placements)

Understanding the Law: Regulation Best Interest and Supervision

Regulation Best Interest (Reg BI) is a critical investor protection rule adopted by the SEC in 2019. It requires brokers to act in the best interest of retail clients, including an explicit “care obligation”: understanding the products being recommended, understanding the customer’s risk profile, and having a reasonable basis that the recommendation is appropriate.

FINRA Rule 3110 obligates every broker-dealer to develop, maintain, and enforce a written supervisory system. The rule is clear: policies that exist only on paper are insufficient. Firms must both monitor and enforce compliance processes to prevent advisor misconduct or honest errors from harming investors.

When Stirlingshire Investments ignored its own written policies, the consequences followed. As Warren Buffett famously said, “Risk comes from not knowing what you’re doing.” In cases like theirs, clients were exposed because the safety net—firm-level oversight—failed.

Lessons for Investors: How to Protect Yourself

Although the penalty—a $40,000 fine and public censure—may appear modest, the reputational damage to Stirlingshire Investments could be far more significant. The firm must correct its lapses and demonstrate ongoing compliance improvements. For investors, several important takeaways emerge:

  • Research your advisor and firm: Use FINRA BrokerCheck to investigate records, complaints, and disciplinary actions.
  • Ask informed questions: If an investment seems complex—such as NT-ETFs—require clear, simple, and specific answers from your financial advisor.
  • Know what you own: Complex products like NT-ET

    Correction or Updated Info Needed? The information in this article includes the publisher's opinion and is based on publicly available materials believed to be accurate at the time of publication.

    We welcome updates. If you have personal knowledge of additional facts or details related to any issues or individuals, and you believe that information would enhance the accuracy of the article, don't hesitate to get in touch with us https://financialadvisorcomplaints.com/article-correction-update/ and provide you name, address, email, and telephone contact for follow-up reporting, along with the back-up for any updates. The publisher strives to provide the most up-to-date and most accurate report regarding all issues and events, and welcomes input from any individuals with personal knowledge.


    DISCLAIMER: The information herein is derived from public sources and is provided "as is" without warranty of any kind. Legal matters may have subsequent developments, and market values may fluctuate. While we strive for accuracy, we make no representations about the completeness or reliability of this information. Readers should independently verify all content and seek professional advice as needed.

Scroll to Top